Free Trial
→ The cat is out the bag (From Porter & Company) (Ad)tc pixel Free ABVX Stock Alerts

Abivax (ABVX) News Today

Abivax logo
$133.45 +3.72 (+2.87%)
As of 09:56 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

ABVX Latest News

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Abivax SA Sponsored ADR (ABVX)
May 27 at 5:48 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/LLY/pressreleases/2148552/analysts-are-bullish-on-top-healthcare-stocks-eli-lilly-co-lly-abivax-sa-sponsored-adr-abvx/
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Barclays
May 27 at 5:48 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2145664/abivax-sa-sponsored-adr-abvx-gets-a-buy-from-barclays/
ABIVAX Société Anonyme (ENXTPA:ABVX) Is Up 6.9% After Long-Term Obefazimod Data And Q1 Results - Has The Bull Case Changed?
May 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/abivax-soci-t-anonyme-enxtpa-071110778.html
Abivax SA Sponsored ADR (ABVX) Gets a Sell from Wedbush
May 23, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2090431/abivax-sa-sponsored-adr-abvx-gets-a-sell-from-wedbush/
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose ...
May 23, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from-study-108-a-phase-2a-2b-open-label-extension-trial-of-obefazimod-following-dose-de-escalation-in-1036189425
Abivax (NASDAQ:ABVX) Upgraded to Hold at Wall Street Zen
May 23, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30794471
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
May 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/22/3300344/0/en/abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from-study-108-a-phase-2a-2b-open-label-extension-trial-of-obefazimod-following-dose-de-esc.html
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of "Moderate Buy" by Analysts
May 19, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30786417
Abivax (ABVX) to Release Quarterly Earnings on Monday
May 18, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30784617
Assessing ABIVAX Société Anonyme (ENXTPA:ABVX) Valuation After Recent Share Price Softness And Conflicting Metrics
May 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/assessing-abivax-soci-t-anonyme-031632976.html
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT) and BillionToOne, Inc. Class A (BLLN)
May 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/BLLN/pressreleases/1798299/analysts-offer-insights-on-healthcare-companies-abivax-sa-sponsored-adr-abvx-arcutis-biotherapeutics-arqt-and-billiontoone-inc-class-a-blln/
Abivax Announces Results of its May 11, 2026 Annual General Meeting
May 11, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/abivax-announces-results-of-its-may-11-2026-annual-general-meeting-1036139165
Brummer Multi Strategy AB Acquires Shares of 14,375 Abivax SA Sponsored ADR $ABVX
May 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-brummer-multi-strategy-ab-acquires-shares-of-14375-abivax-sa-sponsored-adr-abvx-2026-05-11/
Abivax SA Sponsored ADR $ABVX Shares Acquired by Nan Fung Trinity HK Ltd.
May 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-abivax-sa-sponsored-adr-abvx-shares-acquired-by-nan-fung-trinity-hk-ltd-2026-05-10/
Abivax Buys Back $90 Million in Royalties via $45 Million ADS Offering, Keeps Cash Runway to Q4 2027
May 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/abivax-buys-back-90-million-in-royalties-via-45-million-ads-offering-keeps-cash-runway-to-q4-2027?utm_source=marketbeat.com&utm_medium=referral
ABIVAX (ABVX) Announces $90M Agreement to Repurchase Royalty Certificates
May 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/abivax-abvx-announces-90m-agreement-131619226.html
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
May 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/05/3287355/0/en/abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares.html
Jennison Associates LLC Buys Shares of 127,907 Abivax SA Sponsored ADR $ABVX
May 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jennison-associates-llc-buys-shares-of-127907-abivax-sa-sponsored-adr-abvx-2026-05-03/
Pictet Asset Management Holding SA Sells 72,387 Shares of Abivax SA Sponsored ADR $ABVX
May 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-pictet-asset-management-holding-sa-sells-72387-shares-of-abivax-sa-sponsored-adr-abvx-2026-05-02/
Here is Why Abivax (ABVX) is One of the Best Up and Coming Stocks with Highest Upside Potential
May 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/why-abivax-abvx-one-best-101109628.html
Total Clarity Wealth Management Inc. Acquires Shares of 9,245 Abivax SA Sponsored ADR $ABVX
May 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-total-clarity-wealth-management-inc-acquires-shares-of-9245-abivax-sa-sponsored-adr-abvx-2026-05-01/
Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Large Drop in Short Interest
April 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/abivax-sa-sponsored-adr-nasdaqabvx-sees-large-drop-in-short-interest-2026-04-30/
Abivax to Present Data on Obefazimod at Digestive Disease Week®
April 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/22/3279387/0/en/abivax-to-present-data-on-obefazimod-at-digestive-disease-week.html
Abivax Publishes Preparatory Documents for May 11, 2026 General Meeting
April 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/abivax-publishes-preparatory-documents-for-may-11-2026-general-meeting?utm_source=marketbeat.com&utm_medium=referral
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
April 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/20/3277445/0/en/abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents.html
Bright Prospects Ahead for Abivax (ABVX)
April 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/bright-prospects-ahead-abivax-abvx-151955658.html
ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer
April 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/abivax-abvx-appoints-michael-nesrallah-184607870.html
Abivax: Buy Rating on Obefazimod’s Differentiated UC Profile and High-Conviction Phase 3 Maintenance Outlook
April 9, 2026  |  tipranks.comhttps://www.tipranks.com/news/ratings/abivax-buy-rating-on-obefazimods-differentiated-uc-profile-and-high-conviction-phase-3-maintenance-outlook-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Is ABIVAX (ENXTPA:ABVX) Pricing Reflect Its Sharp Multi‑Year Share Price Surge
April 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/abivax-enxtpa-abvx-pricing-reflect-230957198.html
Abivax SA Sponsored ADR
April 5, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/ABVX
ABIVAX SA (ABVX) surged by 58% in Q4
April 2, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/abivax-sa-abvx-surged-by-58-in-q4/ar-AA200Krx
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3266986/0/en/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies.html
Abivax: Obefazimod's Strategic Scarcity Drives Optionality (Maintaining Buy)
April 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4887824-abivax-obefazimods-strategic-scarcity-drives-optionality-maintaining-buy
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim
March 27, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ABVX/pressreleases/975085/abivax-sa-sponsored-adr-abvx-gets-a-buy-from-guggenheim/
Abivax: Going It Alone At A Premium (Rating Downgrade)
March 25, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4885643-abivax-going-it-alone-at-a-premium
Abivax CEO suggests no urgency for deal-making ahead of key trial readout
March 24, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4568041-abivax-ceo-suggests-no-urgency-for-deal-making-ahead-of-key-trial-readout
Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears
March 24, 2026  |  benzinga.comhttps://www.benzinga.com/m-a/26/03/51440538/abivax-ceo-downplays-sale-talk-eyes-capital-raise-as-key-trial-data-readout-nears?utm_source=snapi
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC
March 24, 2026  |  cnbc.comhttps://www.cnbc.com/2026/03/24/abivax-abvxstock-earnings-raise-money-maintenance-trial.html
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
March 23, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/abivax-announces-full-year-2025-financial-results-and-provides-business-updates-1035955956
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and Abivax SA Sponsored ADR (ABVX)
March 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HROW/pressreleases/819290/analysts-offer-insights-on-healthcare-companies-harrow-health-hrow-and-abivax-sa-sponsored-adr-abvx/
Jefferies initiates coverage of ABIVAX Société Anonyme - Depositary Receipt (ABVX) with buy recommendation
March 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/jefferies-initiates-coverage-of-abivax-soci%C3%A9t%C3%A9-anonyme-depositary-receipt-abvx-with-buy-recommendation/ar-AA1YNp8O
Abivax: Maintaining 'Strong Buy' On Buyout Speculation And Obefazimod Advancement
March 16, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4882740-abivax-maintaining-strong-buy-on-buyout-speculation-obefazimod-advancement
Is The Market Getting Ahead Of Itself On ABIVAX (ENXTPA:ABVX) After Multi‑Year Surge
March 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/market-getting-ahead-itself-abivax-230939667.html
Abivax spokesperson denies takeover rumors reported by French media
March 12, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/abivax-spokesperson-denies-takeover-rumors-reported-by-french-media-2026-03-12/
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline
March 12, 2026  |  benzinga.comhttps://www.benzinga.com/m-a/26/03/51206895/eli-lilly-could-rejoin-abivax-bidding-if-astrazeneca-misses-deadline?utm_source=snapi
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), ACADIA Pharmaceuticals (ACAD) and Progyny (PGNY)
March 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ACAD/pressreleases/381604/analysts-offer-insights-on-healthcare-companies-abivax-sa-sponsored-adr-abvx-acadia-pharmaceuticals-acad-and-progyny-pgny/
2 Reasons Abivax Stock Could 10X by 2036
February 27, 2026  |  fool.comhttps://www.fool.com/investing/2026/02/27/2-reasons-abivax-stock-could-10x-by-2036/
Buy Rating Underpinned by Obefazimod’s Differentiated IBD Profile, Oral Convenience, and Upcoming ABTECT & ENHANCE-CD Data Catalysts
February 25, 2026  |  tipranks.comhttps://www.tipranks.com/news/ratings/buy-rating-underpinned-by-obefazimods-differentiated-ibd-profile-oral-convenience-and-upcoming-abtect-enhance-cd-data-catalysts-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Wedbush initiates coverage of ABIVAX Société Anonyme - Depositary Receipt (ABVX) with underperform recommendation
February 24, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/wedbush-initiates-coverage-of-abivax-soci%C3%A9t%C3%A9-anonyme-depositary-receipt-abvx-with-underperform-recommendation/ar-AA1WZCzR
Assessing Whether Abivax (ENXTPA:ABVX) Justifies Its Rich Valuation After A Strong One Year Return
February 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/assessing-whether-abivax-enxtpa-abvx-071224241.html
Get Abivax News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABVX Media Mentions By Week

ABVX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABVX
News Sentiment
▼
0.43

0.46
▲
Average
Medical
News Sentiment

ABVX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABVX Articles
This Week
▼
9

5
▲
ABVX Articles
Average Week

Get the Latest News and Ratings for ABVX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Abivax and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:ABVX) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners
BNZI Breakout Watch: AI Growth Meets Turnaround Setup!
Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...
Huge Alerts | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
A 25,000% opportunity
Angel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...
The Oxford Club | Sponsoredtc pixel
The AI Shakeout Is Coming — Most Investors Won’t Survive
Every major tech shift follows the same pattern: hype, a brutal shakeout, then a handful of winners that take ...
Prosperity Research | Sponsoredtc pixel
SMX Could Be One of the Most Interesting Small Caps Right Now
SMX (Security Matters) Public Limited is developing molecular-level markers embedded into plastics, fuels, met...
Smallcaps Daily | Sponsoredtc pixel